• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲的胃腺癌年轻患者:预后和结局最差

Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes.

作者信息

Calderillo-Ruíz Germán, Díaz-Romero María Consuelo, Carbajal-López Berenice, Herrera-Martínez Marytere, Ruiz-García Erika, Leon-Takahashi Alberto M, López-Basave Horacio Noé, Meneses-García Abelardo, Herrera-Gomez Ángel

机构信息

Gastrointestinal Functional Unit, National Cancer Institute, Mexico City, Mexico.

Clinical Research Department-Gastrointestinal Functional, National Cancer Institute, Mexico City, Mexico.

出版信息

J Gastrointest Oncol. 2023 Oct 31;14(5):2018-2027. doi: 10.21037/jgo-23-259. Epub 2023 Oct 27.

DOI:10.21037/jgo-23-259
PMID:37969836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10643594/
Abstract

BACKGROUND

Incidence of young patients (aged 40 years or younger) diagnosed with gastric carcinoma has increased worldwide. Young GC diagnosis, have clinicopathological features that differ from elderly, and is correlated with bad prognosis factors. The purpose of this work is to describe the prevalence, clinic-pathological features, and prognosis of overall survival (OS) of young Latin-American patients with GC.

METHODS

Retrospective, observational study. Included patients treated at the National Cancer Institute [2004-2020]. Statistical analysis: χ and -test, Kaplan-Meier, Log-Rank and Cox-Regression. Statistical significance differences were assessed when P was bilaterally <0.05.

RESULTS

A total of 2,543 patients fulfilled the inclusion criteria. Young-patients were predominantly female (54%), with diffuse-type adenocarcinoma (68%), signet-ring-cell (72%), poor-differentiation (90%), and metastatic (79%). In OS analysis, patients with metastatic disease, showed differences regarding age, young patients reported a median-OS of 8 versus 13 months for elderly patients (P=0.001). Among young patients, differences were also observed regarding gender, young-female patients had a median-OS of 5 versus 11 months for young-man (P=0.001).

CONCLUSIONS

This is one of the pioneer studies correlating age with gender and the prognostic features of bad prognosis in Latin-American population. Besides, supports the idea that a global effort is required to improve awareness, prevention, and early diagnosis of GC.

摘要

背景

在全球范围内,被诊断为胃癌的年轻患者(40岁及以下)的发病率有所上升。年轻胃癌患者具有与老年患者不同的临床病理特征,且与不良预后因素相关。本研究的目的是描述拉丁美洲年轻胃癌患者的患病率、临床病理特征以及总生存期(OS)的预后情况。

方法

回顾性观察研究。纳入2004年至2020年在国家癌症研究所接受治疗的患者。统计分析:χ²检验和t检验、Kaplan-Meier法、Log-Rank检验和Cox回归分析。当双侧P<0.05时评估统计学显著性差异。

结果

共有2543例患者符合纳入标准。年轻患者以女性为主(54%),主要为弥漫型腺癌(68%)、印戒细胞癌(72%)、低分化癌(90%)以及转移性癌(79%)。在总生存期分析中,有转移疾病的患者在年龄方面存在差异,年轻患者的中位总生存期为8个月,而老年患者为13个月(P=0.001)。在年轻患者中,性别方面也存在差异,年轻女性患者的中位总生存期为5个月,而年轻男性为11个月(P=0.001)。

结论

这是将年龄与性别以及拉丁美洲人群不良预后的预后特征相关联的开创性研究之一。此外,支持了需要全球共同努力以提高对胃癌的认识、预防和早期诊断的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/e68fff9a687c/jgo-14-05-2018-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/6061cd2b78a6/jgo-14-05-2018-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/64edfc3e3bf4/jgo-14-05-2018-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/5c1975e12dc4/jgo-14-05-2018-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/e68fff9a687c/jgo-14-05-2018-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/6061cd2b78a6/jgo-14-05-2018-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/64edfc3e3bf4/jgo-14-05-2018-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/5c1975e12dc4/jgo-14-05-2018-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a0/10643594/e68fff9a687c/jgo-14-05-2018-f4.jpg

相似文献

1
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes.拉丁美洲的胃腺癌年轻患者:预后和结局最差
J Gastrointest Oncol. 2023 Oct 31;14(5):2018-2027. doi: 10.21037/jgo-23-259. Epub 2023 Oct 27.
2
Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients.分析青年和老年胃癌患者的临床病理特征和预后。
Pathol Oncol Res. 2013 Jan;19(1):111-7. doi: 10.1007/s12253-012-9530-z. Epub 2012 May 10.
3
[Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].食管胃交界腺癌与胃窦腺癌临床病理特征及预后的比较
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):149-155.
4
Using nomograms to predict prognostic factors in young colorectal mucinous and signet-ring cell adenocarcinoma patients.使用列线图预测年轻结直肠黏液性和印戒细胞腺癌患者的预后因素。
Biosci Rep. 2019 Jul 18;39(7). doi: 10.1042/BSR20181863. Print 2019 Jul 31.
5
Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma.胃印戒细胞癌的临床病理特征及预后
World J Clin Cases. 2022 Oct 16;10(29):10451-10466. doi: 10.12998/wjcc.v10.i29.10451.
6
Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study.根治性胃切除术后胃癌患者淋巴结转移率的预后意义:一项单中心回顾性研究。
Scand J Gastroenterol. 2022 Jul;57(7):832-841. doi: 10.1080/00365521.2022.2036807. Epub 2022 Mar 16.
7
[Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].残胃癌与胃癌的临床病理特征比较及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):529-534.
8
Clinicopathological features and prognostic analysis of signet ring cell gastric carcinoma: a population-based study.印戒细胞型胃癌的临床病理特征及预后分析:一项基于人群的研究
Transl Cancer Res. 2019 Sep;8(5):1918-1930. doi: 10.21037/tcr.2019.09.06.
9
Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer.胃癌中的性别差异:女性是晚期胃癌预后不良的因素。
Ann Surg Oncol. 2016 Dec;23(13):4344-4351. doi: 10.1245/s10434-016-5448-0. Epub 2016 Jul 28.
10
Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.成纤维细胞生长因子受体4蛋白表达与胃癌的临床病理特征
World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.

引用本文的文献

1
The prognostic impact of body mass index on patients with gastric adenocarcinoma and mucinous adenocarcinoma: a retrospective cohort study.体重指数对胃腺癌和黏液腺癌患者的预后影响:一项回顾性队列研究。
J Gastrointest Oncol. 2025 Feb 28;16(1):41-52. doi: 10.21037/jgo-24-593. Epub 2025 Feb 26.
2
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma.基于主要组织相容性复合体相关差异表达基因的胃腺癌预测模型的预后研究与验证
Transl Cancer Res. 2025 Jan 31;14(1):33-61. doi: 10.21037/tcr-24-707. Epub 2025 Jan 21.
3

本文引用的文献

1
Rising Incidence of Non-Cardia Gastric Cancer among Young Women in the United States, 2000-2018: A Time-Trend Analysis Using the USCS Database.2000 - 2018年美国年轻女性非贲门胃癌发病率上升:一项使用美国癌症统计数据库的时间趋势分析
Cancers (Basel). 2023 Apr 13;15(8):2283. doi: 10.3390/cancers15082283.
2
Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy.探索曲妥珠单抗治疗下晚期HER2阳性胃癌的潜在分子耐药性和克隆进化。
Oncogenesis. 2023 Apr 18;12(1):21. doi: 10.1038/s41389-023-00466-2.
3
Comparison of clinical and pathological features between early-stage gastric-type and intestinal-type differentiated adenocarcinoma: a retrospective study.
Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression.
对欧洲和拉丁美洲人群胃癌的全面组织病理学分析揭示了PDL1、HER2、p53和MUC6表达的差异。
Gastric Cancer. 2025 Mar;28(2):160-173. doi: 10.1007/s10120-024-01578-3. Epub 2025 Jan 5.
早期胃型和肠型分化性腺癌的临床和病理特征比较:一项回顾性研究。
BMC Gastroenterol. 2023 Mar 28;23(1):92. doi: 10.1186/s12876-023-02733-3.
4
Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.多层次蛋白质组学分析揭示弥漫型和肠型胃癌之间的分子多样性。
Nat Commun. 2023 Feb 14;14(1):835. doi: 10.1038/s41467-023-35797-6.
5
Sex and age differences in mortality trends of gastric cancer among Hispanic/Latino populations in the United States, Latin America, and the Caribbean.美国、拉丁美洲和加勒比地区西班牙裔/拉丁裔人群胃癌死亡率趋势的性别和年龄差异。
Lancet Reg Health Am. 2022 Oct 7;16:100376. doi: 10.1016/j.lana.2022.100376. eCollection 2022 Dec.
6
Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination.HER2阳性晚期/转移性胃癌全身治疗的突破:从单药化疗到三联联合治疗
J Gastric Cancer. 2023 Jan;23(1):224-249. doi: 10.5230/jgc.2023.23.e6.
7
Low expression of E-Cadherin and variants associated with diffuse gastric cancer.E-钙黏蛋白低表达与弥漫型胃癌相关。
Rev Invest Clin. 2023 Feb 20;75(1):037-044. doi: 10.24875/RIC.22000257.
8
Incidence trends of gastric cancer among adolescents and young adults.青少年和青年人群中胃癌的发病趋势
J Gastroenterol Hepatol. 2023 Feb;38(2):337. doi: 10.1111/jgh.16095. Epub 2023 Jan 4.
9
Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies.中国 2000 年至 2022 年胃癌患者的生存状况:一项基于医院的全国性系统综述。
J Glob Health. 2022 Dec 17;12:11014. doi: 10.7189/jogh.12.11014.
10
Molecular Pathology of Gastric Cancer.胃癌的分子病理学
J Gastric Cancer. 2022 Oct;22(4):273-305. doi: 10.5230/jgc.2022.22.e35.